Update on genetics and diabetic retinopathy.

Area of Science:

• Ophthalmology
• Genetics
• Endocrinology

Background:

• Clinical risk factors for diabetic retinopathy (DR) are insufficient for predicting individual disease progression.
• A genetic component is suspected to influence DR development and severity.
• Previous genotype-phenotype studies in DR have yielded conflicting results.

Purpose of the Study:

• To investigate the role of genetic factors in diabetic retinopathy.
• To identify potential genetic risk alleles associated with DR progression.

Main Methods:

• Review of multiple smaller studies examining genotype-phenotype correlations in candidate genes.
• Analysis of genes involved in vascular endothelial growth factor, aldose reductase, and advanced glycation end products pathways.

Main Results:

• Reported associations between specific genetic variations and DR have been inconsistent across studies.
• Conflicting results are attributed to small sample sizes, varied study designs, differing clinical endpoints, and population genetic differences.
• No confirmed genetic risk allele for DR has been identified to date.

Conclusions:

• The genetic contribution to diabetic retinopathy remains unclear.
• Larger, well-designed studies are required to elucidate the genetic basis of DR.
• Future research may establish definitive genetic associations for DR risk and progression.